z-logo
Premium
Spatiotemporal gene control by the Cre‐ERT2 system in melanocytes
Author(s) -
Yajima Ichiro,
Belloir Elodie,
Bourgeois Yveline,
Kumasaka Mayuko,
Delmas Véronique,
Larue Lionel
Publication year - 2006
Publication title -
genesis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.093
H-Index - 110
eISSN - 1526-968X
pISSN - 1526-954X
DOI - 10.1002/gene.20182
Subject(s) - biology , cre recombinase , transgene , recombinase , melanocyte , genetically modified mouse , microbiology and biotechnology , gene , gene targeting , reporter gene , genetics , gene expression , recombination , melanoma
The organ‐specific and temporal control of gene activation/inactivation is a key issue in the understanding of protein function during normal and pathological development and during oncogenesis. We generated transgenic mice bearing a tamoxifen‐dependent Cre recombinase (Tyr::Cre‐ERT2) gene expressed under the control of a 6.1 kb murine tyrosinase promoter in order to facilitate targeted spatiotemporally controlled somatic recombination in melanoblasts/melanocytes. Cre‐ERT2 production was detected in tissues containing melanocytes. After tamoxifen induction at various times during embryogenesis and adulthood in a Cre ‐responsive reporter mouse strain, genetic recombination was detected in the melanoblasts and melanocytes of the skin. Thus, the Tyr::Cre‐ERT2 transgenic mice provides a valuable tool for following this cell lineage and for investigating gene function in melanocyte development and transformation. genesis 44:34–43, 2006. © 2006 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom